Evidence map›Paper›PMID 37567751›Full record

SynthesisBMJ open2023

Associations between vision impairment and vision-related interventions on crash risk and driving cessation: systematic review and meta-analysis.

Helen Nguyen, Gian Luca Di Tanna, Kristy Coxon, Julie Brown, Kerrie Ren, Jacqueline Ramke, Matthew J Burton, Iris Gordon, Justine H Zhang, João Furtado and 3 more

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Observational
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 7 countries.

Helen NguyenSchool of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0002-5285-1507
Gian Luca Di TannaGeorge Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia.
Kristy CoxonSchool of Health Sciences, and the Translational Health Research Institute, Western Sydney University-Campbelltown Campus, Campbelltown, New South Wales, Australia.ORCID 0000-0003-4820-0397
Julie BrownGeorge Institute for Global Health, The University of New South Wales, Sydney, New South Wales, Australia.
Kerrie RenSchool of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia.
Jacqueline RamkeInternational Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0002-5764-1306
Matthew J BurtonInternational Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK.
Iris GordonInternational Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK.
Justine H ZhangInternational Centre for Eye Health, London School of Hygiene and Tropical Medicine, London, UK.ORCID 0000-0001-8385-2003
João FurtadoDivision of Ophthalmology, Universidade de São Paulo Faculdade de Medicina de Ribeirão Preto, Ribeirao Preto, São Paulo, Brazil.
Shaffi MdalaOphthalmology Department, Queen Elizabeth Central Hospital, Blantyre, Southern Region, Malawi.
Gatera Fiston KitemaOphthalmology Department, University of Rwanda College of Medicine and Health Sciences, Kigali, Rwanda.
Lisa KeaySchool of Optometry and Vision Science, University of New South Wales, Sydney, New South Wales, Australia l.keay@unsw.edu.au.
UNSW Sydney · AULondon School of Hygiene & Tropical Medicine · GBCamden and Campbelltown Hospitals · AUMoorfields Eye Hospital NHS Foundation Trust · GBQueen Elizabeth Central Hospital · MWUniversidade de Ribeirão Preto · BRUniversity of Applied Sciences and Arts of Southern Switzerland · CHUniversity of Auckland · NZUniversity of Rwanda · RW

Funding

Wellcome TrustWellcome Trust 20190426_PH2Wellcome Trust 207472/Z/17/Z
6 · The paper itself

Abstract

objectivesTo systematically investigate the associations between vision impairment and risk of motor vehicle crash (MVC) involvement, and evaluate vision-related interventions to reduce MVCs.

designMedline (Ovid), EMBASE and Global Health electronic databases were systematically searched from inception to March 2022 for observational and interventional English-language studies. Screening, data extraction and appraisals using the Joanna Briggs Institute appraisal tools were completed by two reviewers independently. Where appropriate, measures of association were converted into risk ratios (RRs) or ORs for meta-analysis.

participantsDrivers of four-wheeled vehicles of all ages with no cognitive declines. PRIMARY AND SECONDARY OUTCOMES: MVC involvement (primary) and driving cessation (secondary).

results101 studies (n=778 052) were included after full-text review. 57 studies only involved older drivers (≥65 years) and 85 were in high-income settings. Heterogeneity in the data meant that most meta-analyses were underpowered as only 25 studies, further split into different groups of eye diseases and measures of vision, could be meta-analysed. The limited evidence from the meta-analyses suggests that visual field defects (four studies; RR 1.51 (95% CI 1.23, 1.85); p<0.001; I

conclusionImpaired vision identified through a variety of measures is associated with both increased MVC involvement and cessation. Cataract surgery can reduce MVC risk. Despite literature being highly heterogeneous, this review shows that detection of vision problems and appropriate treatment are critical to road safety. PROSPERO REGISTRATION NUMBER: CRD42020172153.

Indexed as

CataractMacular DegenerationAccidents, TrafficHumansRanibizumabVision DisordersVisual AcuityRanibizumabepidemiologyophthalmologypublic health

Identifiers

PMID37567751
PMCPMC10423787
OpenAlexW4385778858

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.